Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,625,712
  • Shares Outstanding, K 145,678
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,868 M
  • EBITDA $ 2,103 M
  • 60-Month Beta 0.88
  • Price/Sales 7.29
  • Price/Cash Flow 22.98
  • Price/Book 5.93

Options Overview Details

View History
  • Implied Volatility 28.77% (-0.66%)
  • Historical Volatility 32.63%
  • IV Percentile 51%
  • IV Rank 23.16%
  • IV High 56.66% on 04/08/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 16) 11.91 (4.61%)
  • Put/Call Vol Ratio 34.33
  • Today's Volume 424
  • Volume Avg (30-Day) 379
  • Put/Call OI Ratio 2.67
  • Today's Open Interest 12,020
  • Open Int (30-Day) 14,714
  • Expected Range 246.38 to 270.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.77
  • Number of Estimates 6
  • High Estimate 2.84
  • Low Estimate 2.69
  • Prior Year 2.37
  • Growth Rate Est. (year over year) +16.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
245.65 +5.46%
on 02/12/26
277.67 -6.71%
on 02/10/26
-3.98 (-1.51%)
since 02/04/26
3-Month
240.00 +7.94%
on 01/02/26
277.67 -6.71%
on 02/10/26
+7.54 (+3.00%)
since 12/04/25
52-Week
199.92 +29.58%
on 04/07/25
293.81 -11.83%
on 08/22/25
+27.57 (+11.91%)
since 03/04/25

Most Recent Stories

More News
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains  53% of people surveyed rank sleep as the most important behavior for a long,...

RMD.AX : 36.340 (+0.97%)
RMD : 259.05 (+0.30%)
Richmond Commences Drilling Program at Aguara East

TORONTO, ON / ACCESS Newswire / February 26, 2026 / Richmond Minerals Inc. (TSX-V:RMD) ("Richmond" or the "Company") is pleased to provide an update for exploration work at the Company's Ridley Lake Gold...

RMD.VN : 0.075 (+25.00%)
RMD : 259.05 (+0.30%)
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution...

RMD.AX : 36.340 (+0.97%)
RMD : 259.05 (+0.30%)
ResMed Stock Outlook: Is Wall Street Bullish or Bearish?

As ResMed has outpaced the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

$SPX : 6,869.50 (+0.78%)
MS : 167.58 (+0.98%)
RMD : 259.05 (+0.30%)
IHI : 58.81 (-0.32%)
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?

ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?

RMD : 259.05 (+0.30%)
3 Quality Compounders to Consider Right Now

3 Quality Compounders to Consider Right Now

FIX : 1,430.38 (+2.82%)
RMD : 259.05 (+0.30%)
APH : 132.75 (+2.45%)
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call

The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call

RMD : 259.05 (+0.30%)
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth

RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth

RMD : 259.05 (+0.30%)
ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations

ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations

RMD : 259.05 (+0.30%)
ResMed: Fiscal Q2 Earnings Snapshot

ResMed: Fiscal Q2 Earnings Snapshot

RMD : 259.05 (+0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 266.79
2nd Resistance Point 263.39
1st Resistance Point 260.84
Last Price 259.05
1st Support Level 254.89
2nd Support Level 251.49
3rd Support Level 248.94

See More

52-Week High 293.81
Last Price 259.05
Fibonacci 61.8% 257.94
Fibonacci 50% 246.86
Fibonacci 38.2% 235.79
52-Week Low 199.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar